Aviva reports a 28% increase in new sales in Q1 on bulk annuities

Aviva reports a 28% increase in new sales in Q1 on bulk annuities

  • Aviva's life business posts a 28% increase in new sales to £12.3 billion in the first quarter.
  • The British insurer forecasts £160 million in claims related to the Coronavirus pandemic.
  • General insurance net written premiums climb by 3% to £2.4 billion in the recent quarter.

Aviva (LON: AV) said on Thursday that its life business posted a 28% increase in new sales in the first quarter to £12.3 billion. The company attributed upbeat sales to bulk annuities in Q1. The British multinational insurance company, however, forecast £160 million in claims primarily on travel insurance and business interruptions due to the Coronavirus pandemic.

At £2.4 billion, the UK insurer announced a 3% increase in its net written premiums (general insurance), as per Aviva’s report on Thursday.

Shares of the insurance company were reported about 2% up in premarket trading on Thursday. At 240 pence per share, Aviva is currently a little under 45% down year to date in the stock market.

Aviva forecasts downbeat sales in the second quarter

Apart from the United Kingdom, Aviva is also operational in Canada, Asia and mainland Europe. Based on the trends at the start of the second quarter, the company said that many of its businesses are likely to take a hit in terms of new business sales in Q2 ascribed to government-imposed nationwide lockdowns to minimize the fast spread of the flu-like virus. As per CFO Jason Windsor of Aviva:

“We’ve had a pretty good first quarter. Q2 could look pretty different, we know there will be materially lower activity.”

The pandemic that has so far infected more than 5 million people worldwide and caused over 329,500 deaths, Aviva added, is likely to create unprecedented challenges for Aviva to hit its targets for 2022.

According to Lloyd’s of London, the ongoing health crisis is estimated to result in over £87 billion in underwriting losses for insurers from across the globe in 2020.  

Aviva may face litigation from small businesses in the UK

Multiple leading insurers are currently being speculated to face legal action from the UK’s small businesses that are struggling to get payments to cover for COVID-19 driven business interruptions.

Serving as an advisor to several hospitality businesses in Britain, Mishcon de Reya (law firm) announced earlier this week that it is considering a potential claim on the London-headquartered insurer.

Aviva’s downward rally in the stock market due to the outbreak started in late February and ended in a year to date low of 211 pence per share in March. The British multinational insurance company performed fairly upbeat in 2019 with an annual gain of about 10%.

Aviva is currently valued at £9.44 billion and has a price to earnings ratio of 3.81.  

By Wajeeh Khan
Mr. Khan specialises in Public Health by academia but is a trader by passion. Taking up two new hobbies of writing and trading in his teen years, he is now a professional trader and news writer with over 5 years of experience in various financial markets. Khan is passionate about bringing insightful articles to his readers and hopes to add value to their portfolios.

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.